The company
Shoulder Innovations, Inc.
SI · NYSE
SI stood above a rising 150-day average in 25 of the last 29 weekly readings, including each of the last 3 weeks. It is 1.9% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 3 in a row
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $293K
- Insider sales, 12 months
- $10.9M
- Officials’ trades on record
- 6
- Institutions holding
- 73 (+17)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 25 of 29 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
6 disclosed lines: House 3, Senate 3, executive 0; 3 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Chris Jacobs House: U.S. House ClerkNY27 | sold | $1k–$15k | 8 Nov 2022filed 12 Dec 2022 |
| Chris Jacobs House: U.S. House ClerkNY27 | bought | $1k–$15k | 18 Jul 2022filed 9 Sep 2022 |
| Thomas R. Carper Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 31 Jan 2022filed 3 Feb 2022 |
| Thomas R. Carper Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 20 Nov 2020filed 17 May 2021 |
| Thomas R. Carper Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 20 Nov 2020filed 2 Dec 2020 |
| Rubén Hinojosa House: U.S. House ClerkTX15 | sold | $1k–$15k | 20 Sep 2013filed 15 Apr 2015 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Robert Joseph BallCEO & Executive Chairman | sold | 10,175at $18.45 | 14 Sep 2026filed 14 Sep 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 1,196at $22.60 | 26 Aug 2026filed 28 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 681at $22.62 | 24 Aug 2026filed 24 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 20,516at $22.61 | 21 Aug 2026filed 24 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 3,900at $22.60 | 20 Aug 2026filed 24 Aug 2026 |
| Matthew Fraser AhearnChief Operating Officer | sold | 12,586at $20.94 | 18 Aug 2026filed 18 Aug 2026 |
| Matthew Fraser AhearnChief Operating Officer | sold | 1,600at $21.38 | 18 Aug 2026filed 18 Aug 2026 |
| Matthew Fraser AhearnChief Operating Officer | sold | 8,314at $20.10 | 17 Aug 2026filed 18 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 2,095at $22.60 | 6 Aug 2026filed 7 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 7,338at $22.64 | 5 Aug 2026filed 7 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 99,812at $22.77 | 4 Aug 2026filed 5 Aug 2026 |
| Gilde Healthcare Holding B.v.10% owner | sold | 10,751at $22.71 | 3 Aug 2026filed 5 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCreduced · filed 13 Aug 2026 | 3,673,960$74.5M | -110,592−2.9% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 638,420$12.9M | +82,368+14.8% |
| SECTORAL ASSET MANAGEMENT INCunchanged · filed 14 Aug 2026 | 430,407$8.7M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 392,181$8.0M | -21,299−5.2% |
| KCM Capital Incadded · filed 12 Aug 2026 | 300,000$6.1M | +265,000+757.1% |
| TimesSquare Capital Management, LLCreduced · filed 7 Aug 2026 | 298,219$6.0M | -24,545−7.6% |
| Roubaix Capital, LLCreduced · filed 10 Aug 2026 | 255,288$5.2M | -1,833−0.7% |
| Driehaus Capital Management LLCnew · filed 14 Aug 2026 | 253,760$5.1M | +253,760 |
| Parkman Healthcare Partners LLCnew · filed 14 Aug 2026 | 226,212$4.6M | +226,212 |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 199,529$4.0M | +15,850+8.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.